Liver cancer is an extraordinarily heterogeneous malignant disease among the tumors that
have so far been identified. Hepatocellular carcinoma (HCC) arises most frequently in the …

As the number of effective treatment options has increased, the management of patients with
hepatocellular carcinoma has become complex. The most appropriate therapy depends …

Abstract Background and Aim To determine and compare the adverse events and long‐term
effectiveness for patients with small hepatocellular carcinoma (HCC)(≤ 3 cm) treated by …

Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer that is derived from
hepatocytes and is characterised by high mortality rate and poor prognosis. While HCC is …

Intratumoral (IT) drug injections reduce systemic toxicity, but delivered volumes and
distribution can be inconsistent. To improve IT delivery paradigms, porphyrin–phospholipid …

Abstract Background and Aims The nuclear factor of the activated T cell (NFAT) family was
primarily recognized for its central role in T lymphocyte activation. Recent evidence showed …

Background Inoperable hepatocellular carcinoma (HCC) can be treated with laparoscopic
radiofrequency ablation (LRFA), which is generally a more accurate and accessible …

AIM: To assess the usefulness of contrast-enhanced ultrasound (CEUS) during follow-up
after percutaneous ablation therapy for hepatocellular carcinoma (HCC). METHODS: A total …

Liver transplantation (LT), one of the radical methods of treating liver cancer, has brought
new hope for the treatment of unresectable liver cancer. Currently, patients who meet …

The purpose of this study was to retrospectively evaluate the safety and efficacy of
cryoablation and compare the outcomes with those of percutaneous ethanol injection (PEI) …